Treating EGFR Exon 20 Insertion+ mNSCLC: Equipping Oncology Nurses to Optimize Care

Deepen your understanding of treating EGFR exon 20 insertion&ndash positive metastatic NSCLC with this comprehensive nursing program featuring an on-demand webcast and downloadable slidesets from a live symposium along with a Clinical Resource PDF to help you talk with your patients about adverse events with agents targeting EGFR exon 20 insertion mutations.

Share

Program Content

Activities

<i>EGFR</i> ex20ins+ NSCLC: Testing and Therapy
Identification and Treatment of Advanced NSCLC With EGFR Exon 20 Insertion Mutations
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 29, 2022

Expires: April 28, 2023

<i>EGFR</i> ex20ins+ NSCLC: Toxicity
Understanding and Managing the Toxicity Profile of New Agents Targeting EGFR Exon 20 Insertions in Patients With Advanced NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 29, 2022

Expires: April 28, 2023

<i>EGFR</i> ex20ins+ NSCLC:  <i>ExpressPoints</i>
ExpressPoints
Treating EGFR Exon 20 Insertion+ mNSCLC: Equipping Oncology Nurses to Optimize Care
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 11, 2022

Expires: May 10, 2023

Activities

<i>EGFR</i> ex20ins Tx AE Care
Managing Adverse Events With New Treatments Targeting EGFR Exon 20 Insertion Mutations in Patients With Advanced NSCLC
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: April 28, 2022

Expires: April 27, 2023

No activities added yet

Faculty

cover img faculity

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP

Associate Professor
Coordinator of Oncology Concentration

Yale University School of Nursing
Oncology Nurse Practitioner
Medical Oncology
Smilow Cancer Hospital at Yale-New Haven
New Haven, Connecticut

cover img faculity

Matthew Gubens, MD, MS

Associate Professor
Thoracic Oncology
University of California, San Francisco
San Francisco, California

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Takeda Pharm USA